does glp 1 interact with any medications Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review GLP-1 for Diabetes vs GLP-1
Description
That's the right next step

Hengrui Pharma & Kailera Therapeutics Present Additional Data from Phase 3 Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531 at Obesity Week...

Altimmune's dual-agonist pemvidutide faces key 2026 tests in MASH and alcohol-related diseases that could validate its multi-pathway liver strategy.

Medication Ships
Image Credit: Visual Capitalist Data: S&P global, GLP-1 Men, Financial times, IFEBP & Reuters #biotech #biopharma #GLP1 #obesity | 14 comments on LinkedIn
